News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–4
Matches
4
Sources here
2
Companies here
1
Search results Stored financial headlines

Active search

4 matching headlines

Ticker or company: G1SK34Main company stories
Clear

GSK PLC (GSK) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Accelerated Pipeline ...

This article first appeared on GuruFocus. Revenue: Q2 sales up 5% to more than GBP8.4 billion. Core Operating Profit: Grew 7%. Core Earnings Per Share (EPS): Up 9%. Cash Generation: Positive at GBP4.3 billion. Q2 Dividend: 17p. Gross Margin: Improved 250 basis points due …

G1SK34 main company
Sharemaestro market context Price below Trend Line 52 weeks +22.0% · Next-week setup positive 56.8% G1SK34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

New survey reveals Canadians underestimate chronic hepatitis B and its link to liver cancer

Nearly 9 in 10 Canadians have little to no awareness of chronic hepatitis B (CHB) Only 31% rank CHB as a high cancer risk, revealing a significant gap between perception and reality Just 14% report to have been tested for CHB, yet CHB causes …

G1SK34 main company
Sharemaestro market context Price below Trend Line 52 weeks +22.0% · Next-week setup positive 56.8% G1SK34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

GSK Lands FDA Approval for Nuvalent-Acquired Jideytro for NSCLC

GSK plc GSK announced that the FDA has approved Jideytro (zidesamtinib) for previously treated ROS1-positive non-small cell lung cancer (NSCLC). Jideytro was added as a late-stage candidate to GSK's oncology portfolio through the recently closed acquisition of Nuvalent. Jideytro is a next-generation, highly selective …

G1SK34 main company
Sharemaestro market context Price below Trend Line 52 weeks +22.0% · Next-week setup positive 56.8% G1SK34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context